Table 5.
Hormone | Quantity of studies (% of total basal and resting levels) | Normal levels (%) | Reduced levels (%) | Increased levels (%) |
---|---|---|---|---|
Cortisol | 22 (53.7%) | 16 (72.7%) | 5 (22.7%) | 1 (4.6%) |
Total T | 17 (41.5%) | 11 (64.7%) | 5 (29.4%) | 1 (5.9%) |
T/C ratio | 12 (29.3%) | 6 (50.0%) | 5 (41.7%) | 1 (8.3%) |
ACTH | 10 (24.4%) | 8 (80.0%) | - | 2 (20.0%) |
GH | 9 (21.9%) | 5 (55.6%) | 2 (22.2%) | 2 (22.2%) |
NUC | 8 (19.5%) | 4 (50.0%) | 2 (25.0%) | 2 (25.0%) |
Plasma Catecholamines | 8 (19.5%) | 5 (62.5%) | 2 (25.0%) | 1 (12.5%) |
IGF-1 | 6 (14.6%) | 5 (83.3%) | 1 (16.7%) | - |
Insulin | 6 (14.6%) | 5 (83.3%) | 1 (16.7%) | - |
LH | 5 (12.2%) | 4 (80.0%) | 1 (20.0%) | - |
FSH | 4 (9.8%) | 3 (75.0%) | 1 (25.0%) | - |
Free T | 4 (9.8%) | 2 (100%) | 1 (25.0%) | 1 (25.0%) |
Aldosterone | 4 (9.8%) | 2 (50.0%) | 1 (25.0%) | 1 (25.0%) |
Prolactin | 4 (9.8%) | 4 (100%) | - | - |
TSH | 2 (4.9%) | 2 (100%) | - | - |
T4 | 2 (4.9%) | 2 (100%) | - | - |
T3 | 2 (4.9%) | 2 (100%) | - | - |
SHBG | 2 (4.9%) | 1 (50.0%) | - | 1 (50.0%) |
IGFBP-3 | 2 (4.9%) | 1 (50.0%) | 1 (50.0%) | - |
IGF-1/IGFBP-3 | 2 (4.9%) | 1 (50.0%) | - | 1 (50.0%) |
Peptide F | 2 (4.9%) | 2 (100%) | - | - |
Salivary C | 2 (4.9%) | - | 2 (100%) | - |
Salivary T | 2 (4.9%) | 1 (50.0%) | 1 (50.0%) | - |
T/SHBG | 1 | 1 | - | - |
4 PM salivary C | 1 | - | - | 1 |
Fertility | 1 | - | 1 | - |
Beta-2 muscle receptors | 1 | - | 1 | - |
NUC Nocturnal urinary catecholamines, T/C testosterone/cortisol ratio, T/SHBG testosterone/sex hormone binding globulin, T3 thyronine, T4 thyroxine, salivary C salivary cortisol, salivary T salivary testosterone, 4 PM salivary C salivary cortisol collcted at 4 PM, IGF-1/IGFBP-3 IGF-1/IGFBP3 ratio, fertility evaluation by semen analysis